Core Viewpoint - The company has entered into a strategic cooperation memorandum with Mingzhi Medical Technology (Shanghai) Co., Ltd. to integrate core resources using artificial intelligence technology, focusing on real-world research in oncology and innovation in traditional Chinese medicine [1][2] Group 1: Strategic Cooperation - The memorandum aims to promote deep integration and industrial upgrading of "medical + technology + scenarios" [1] - The collaboration will leverage Mingzhi Medical's technological and resource advantages to support the company's transition from traditional property and asset management to a digital AI healthcare service enterprise [1] - Specific cooperation directions include building a digital marketing management system for pharmaceutical companies and a collaborative platform for digital clinical trials [1] Group 2: Business Diversification - The company operates two reportable segments: property management and property development and investment, with operations in China, the United States, and the United Kingdom [2] - The strategic cooperation is expected to enhance the company's financial performance and profitability, aligning with the overall interests of the company and its shareholders [2] - The company is actively seeking business diversification to broaden its revenue sources and improve shareholder returns [2]